Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Treatment

Researchers Reveal Selenium's Metabolism In Life-Giving Amino Acids
US researchers have discovered the molecular mechanisms by which the human body metabolizes selenium, a trace element that plays an essential
generic viagra online
Trinam(R) Phase III Study Enrols First Patient
Ark Therapeutics Group plc ("Ark" or the "Company") announces that the first patient has been enrolled into the US Phase III study for Trinam®. Trinam® is Ark"s novel gene-based medicine to prevent blood vessels blocking in kidney dialysis patients who have undergone vascular access graft surgery. The product is an adenovirus-mediated VEGF D gene delivered with a novel biodegradeable local delivery device (EG001).
News of the day
New Algorithm For Ruptured Aneurysms Improves Mortality Rate
Researchers from the University of Washington in Seattle report that algorithms for the management of ruptured abdominal aortic aneurysm (rAAA) with a preference for endovascular repair (EVAR), serve as surrogates for an organized approach to managing the disease process and reducing overall mortality. These findings are from a study presented at the 63rd Annual Meeting of the Society for Vascular Surgery®.
Cardiovascular

Oxoid Provides Free Infection Control Seminar In The UK

Oxoid, a world leading microbiology brand, is pleased to announce that the next Oxoid Infection Control Seminar will take place on 02 June 2009 at The Belfry, West Midlands, UK. This all-day event is completely free of charge and is provided as an educational service to consultant microbiologists, laboratory managers/personnel and infection control professionals. This year"s topics and speakers include: - An outbreak of the new superbug - MSSA (Dr Tim Boswell Nottingham University Hospital NHS Trust) - The implications of PVL for infection control (Angela Kearns, Health Protection Agency) - Implications and benefits of implementation of MRSA screening policy (Steve Farley and Yashpal Delele, Dudley Group of Hospitals NHS Trust) - European Committee on Antimicrobial Susceptibility Testing (EUCAST) Update, (Gunnar Kahlmeter, Vç¤xjç¶ Hospital, Sweden) - New technology, friend or foe - how infection control needs are impacting hospital design (Martin Kiernan, President of the Infection Prevention Society) - Standards and Performance Indicators for Healthcare Associate Infections and Antimicrobial Resistance in Europe (Professor Barry Cookson, Health Protection Agency). This study day is accredited by the Institute of Biomedical Scientists (7 credits) and the Royal College of Pathologists (5 credits) and accreditation from the Royal College of Nursing has been sought. The seminar is also a great opportunity to mix with colleagues and share current thinking on healthcare associated infection and infection control matters during the coffee and lunch breaks. So make sure you reserve the date and your FREE place by contacting Fiona Macrae, seminar manager, email: oxoid.awards@thermofisher.com tel: 01256 841144. Places are limited and are allocated on a first come, first served basis. Lunch is provided, but travel and accommodation are not included in this offer. Oxoid is part of Thermo Fisher Scientific Inc., the world leader in serving science. Thermo Fisher Scientific


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009